GlassScriptPhysician profile
Grace Wen Kim
NPI 1609004415
$9,742.60
in general payments reported to CMS, 2019-2025
57 companies · $2,100 in 2025
The $2,100 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,205 · 2020: $777 · 2021: $1,271 · 2022: $1,244 · 2023: $1,231 · 2024: $1,914 · 2025: $2,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,244.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,801.08 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $1,360.30 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $696.95 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $502.72 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $452.64 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $390.23 | 2019-2023 | Belsomra, Steglatro, Steglujan |
| Amgen INC. | $360.94 | 2020-2025 | Repatha, Otezla, Otezla |
| Phathom Pharmaceuticals, INC. | $330.40 | 2024-2025 | Voquezna |
| Abbvie INC. | $311.45 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $216.66 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $196.85 | 2019-2024 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $194.71 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $187.29 | 2019-2024 | |
| Inspire Medical Systems, INC. | $172.54 | 2023-2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $169.11 | 2021-2025 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.